RxDoctor Payments Data

Michelle Wasden, PA

Physician Assistant · Pleasant View, UTNPI 1700875333

Payments from drug & device makers

$1,434in general payments, 2019–2025

Across 85 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$317
  • Pfizer$220
  • GSK$155
  • Astellas Pharma US Inc$81
  • Corium, LLC$76
  • Biohaven Pharmaceutical Holding Company Ltd.$74
  • plus $511 from 19 others

What the payments were for

  • Food & beverage$1,434100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,434 in reported general payments places this provider in the 75th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$37,344
Medicare patients
131
Services billed
1,002

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$32,020
JanuviaSitagliptin Phosphate19$19,022
MounjaroTirzepatide13$13,977
EliquisApixaban12$7,177
Omeprazole89$1,627
Levothyroxine Sodium149$1,563
Meloxicam148$766
Estradiol32$757
Celecoxib25$650
Ibandronate Sodium26$581
Atorvastatin Calcium65$570
Rosuvastatin Calcium41$524
Amitriptyline Hcl22$519
Simvastatin57$505
Sertraline Hcl55$498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$49$32,02026 claims
MerckJanuvia$16$19,02219 claims
Lilly USA, LLCMounjaro$44$13,97713 claims
PfizerEliquis$220$7,17712 claims
AbbVieArmour Thyroid$317$34911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Pleasant View

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →